Selenium Supplementation and Gestational Diabetes: A Randomised Controlled Trial

Selenium Supplementation and Gestational Diabetes: A Randomised Controlled Trial

Objective

To evaluate the impact of selenium supplementation on blood glucose levels in women with gestational diabetes mellitus (GDM).

Study Design

Randomised controlled trial conducted at the Department of Internal Medicine, Istanbul Medipol University, Faculty of Medicine, Istanbul, Turkiye, from February to July 2023.

Methodology

Pregnant women’s selenium levels were measured during an oral glucose tolerance test. Those diagnosed with GDM were randomly assigned to two groups: one receiving diet alone and the other receiving diet plus selenium supplementation (200 µg/day) for 4 weeks.

Results

– Pregnant women with GDM had significantly lower selenium levels compared to healthy pregnant women.
– Low selenium levels (<80 ng/ml) were associated with a 2.709-fold higher risk for GDM. - Fasting blood glucose levels decreased significantly in both groups, with a greater decrease observed in the selenium recipients. - Selenium recipients also showed lower fasting, 1st and 2nd hour blood glucose levels compared to those who only received diet.

Conclusion

Selenium supplementation had a beneficial impact on blood glucose levels in pregnant women with GDM compared to diet alone.

Key Words

Pregnancy, Pregnancy outcome, Diabetes, Gestational, Dietary supplements, Selenium.

Practical Solutions and Value

Clinical trials are crucial for developing safe and effective treatments. Our AI-driven platform, DocSym, consolidates ICD-11 standards, clinical protocols, and research into an easily accessible knowledge base for clinicians. Additionally, our mobile apps support scheduling, monitoring treatments, and telemedicine, streamlining operations and improving patient outcomes.

By leveraging AI, clinics can enhance workflows, reduce paper routines, and expand services digitally. Learn more about how we can help at aidevmd.com.